TMEM192 inhibitors represent a class of compounds designed to selectively interfere with the activity of the transmembrane protein 192 (TMEM192), a protein whose function is not fully characterized but is thought to be associated with cellular processes such as intracellular trafficking and signaling. These inhibitors are typically small molecules that can cross cell membranes to access intracellular TMEM192, allowing them to exert their effects directly on the protein within its native cellular environment. By binding to TMEM192, these inhibitors alter the protein's conformation and disrupt its normal function, which could include modulation of endosomal processes or interactions with other cellular proteins important for maintaining homeostasis. The specificity of TMEM192 inhibitors is crucial as it ensures that the impact on cellular function is as targeted as possible, reducing the likelihood of off-target effects that could disrupt other cellular pathways. The development of these inhibitors often requires a deep understanding of the protein's structure and the molecular dynamics that govern its interactions with other cellular components.
The mode of action of TMEM192 inhibitors is predicated on their ability to bind to particular domains of the protein, which are essential for TMEM192's role in cellular functioning. This interaction can lead to the inhibition of TMEM192's activity, preventing it from participating in its normal cellular roles or from interacting with other proteins or molecules. The cascade of cellular events following the inhibition of TMEM192 can have various downstream effects, such as altering intracellular signaling pathways or trafficking patterns. While the precise cellular consequences of inhibiting TMEM192 depend on the context of the cell type and the biological processes in which TMEM192 is involved, the inhibitors are designed to exert a controlled blockade of TMEM192's function, thereby providing a tool for dissecting the protein's role and for studying complex intracellular pathways in which TMEM192 is implicated. The design of these inhibitors takes into account the unique topology and biochemistry of TMEM192, ensuring that they are both effective in their inhibitory role and selective enough to minimize unintended interactions with other proteins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent non-selective inhibitor of protein kinases, including PKC, which can affect various cellular pathways. Inhibition of PKC can reduce the phosphorylation status of several proteins, potentially altering the intracellular localization and function of TMEM192 as it is implicated in cellular trafficking. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an isoflavone that acts as a tyrosine kinase inhibitor. It can inhibit a variety of signaling pathways, including those involved in vesicular transport. By inhibiting these pathways, Genistein may indirectly impair the vesicular trafficking function of TMEM192. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus by inhibiting ADP-ribosylation factor (ARF), a small GTPase involved in vesicle formation. As TMEM192 is associated with intracellular trafficking, disruption of the Golgi could inhibit its functional role in vesicle transport. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is a selective inhibitor of the N-WASP, which is involved in actin polymerization. Since TMEM192 may be associated with vesicle movement along the cytoskeleton, inhibiting N-WASP could indirectly reduce its functional activity. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a small molecule that inhibits dynamin, a GTPase important for endocytosis. Inhibition of dynamin could disrupt endocytic recycling pathways and thus, indirectly affect the function of TMEM192 in endosomal trafficking. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits Rac1, a small GTPase involved in actin cytoskeleton reorganization. As vesicle transport is cytoskeleton-dependent, the inhibition of Rac1 could indirectly decrease the functional activity of TMEM192 in cell trafficking. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective inhibitor of Cdc42, another GTPase that regulates cytoskeletal dynamics. Since TMEM192's activity may be tied to cytoskeletal-based vesicle transport, Cdc42 inhibition could indirectly affect TMEM192 function. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D is a potent inhibitor of actin polymerization. By destabilizing the actin cytoskeleton, it could indirectly inhibit the vesicular transport processes in which TMEM192 is potentially involved. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and prevents polymerization. This could lead to a reduction in vesicle transport efficiency, thereby indirectly inhibiting TMEM192-associated transport pathways. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization. TMEM192, being potentially involved in vesicle transport along microtubules, could have its function indirectly inhibited by prevention of microtubule assembly. | ||||||